To amend the Public Health Service Act to update quality standards for mammography facilities for the use of AI systems, and for other purposes.

HR8526, titled "To amend the Public Health Service Act to update quality standards for mammography facilities for the use of AI systems, and for other purposes," was introduced in the House on April 27, 2026, by Rep. Schweikert (R-AZ). It was subsequently referred to the House Committee on Energy and Commerce on the same day. This action signifies the initial step in the legislative process, where the bill will undergo committee review and potential amendments. This bill does not explicitly authorize or appropriate any specific funding amounts. Its primary mechanism is to establish new quality standards, which would likely necessitate investment by mammography facilities in AI-powered diagnostic tools and systems. The financial burden and opportunities would fall on healthcare providers and technology developers, respectively, as they adapt to these updated standards. No direct government funding is allocated through this bill. Structural winners would include companies developing and providing AI diagnostic software and hardware solutions for medical imaging, particularly in mammography. Companies specializing in medical device manufacturing and healthcare IT could see increased demand for their products and services. However, without specific companies or technologies mentioned in the bill, identifying precise tickers is speculative. Companies involved in medical imaging technology and AI development for healthcare are generally positioned to benefit. There are no clear losers identified at this early stage, though facilities that are slow to adopt new technologies may face compliance challenges. As of April 28, 2026, the bill is in its earliest legislative phase, having only been introduced and referred to committee. Significant legislative steps remain, including committee hearings, potential markups, a committee vote, and votes by the full House and Senate, followed by presidential assent. The timeline for passage is uncertain and could extend over several months or even years.